Negative-sense RNA viruses (NSVs) include many highly prevalent human pathogens that can be responsible for respiratory infections, haemorrhagic fever and encephalitis. NSVs can also cause disease in livestock, arthropods and plants and are considered a substantial economic burden worldwide. In humans, NSVs are responsible for frequent epidemics, such as those caused by human respiratory syncytial virus (HRSV), human parainfluenza viruses, measles virus, mumps virus and the influenza A virus (IAV) and influenza B virus (IBV). NSVs that exist in animal reservoirs can cause occasional zoonotic outbreaks that are often associated with high mortality and morbidity, such as avian IAVs, Ebola virus (EBOV), Lassa mammarenavirus (LASV) and rabies lyssavirus (RABV). A better understanding of the molecular mechanisms underlying NSV replication and the development of new antiviral drugs against NSV infections are therefore essential to combat the impact of these viruses.The genome of NSVs consists of one or more single-stranded, negative-sense RNA molecules that are assembled with multiple copies of viral nucleoprotein into megadalton-sized viral ribonucleoprotein (vRNP) complexes with a helical configuration 1 (Box 1). The nucleoproteins are the main determinants of this helical configuration and oligomerize to form a scaffold for the genomic viral RNA (vRNA). In non-segmented NSVs (nsNSV), these vRNP structures are highly symmetrical and relatively rigid 1,2 . In segmented NSVs (sNSVs), each individual segment is contained in a Negative-sense RNA viruses (NSVs). Viruses with a negativesense, single-stranded RNA genome.